Education
About Us
Working with TipRanks
Follow Us
Alphamab Oncology (HK:9966)
:9966
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 640.08M | ¥ 218.77M | ¥ 166.84M | ¥ 146.02M | ¥ 0.00 |
| Gross Profit | ¥ 579.77M | ¥ 163.54M | ¥ 122.64M | ¥ 142.99M | ¥ 0.00 |
| Operating Income | ¥ 101.01M | ¥ -305.55M | ¥ -432.37M | ¥ -415.62M | ¥ -409.45M |
| EBITDA | ¥ 156.79M | ¥ -129.30M | ¥ -391.83M | ¥ -358.13M | ¥ -390.47M |
| Net Income | ¥ 166.34M | ¥ -210.59M | ¥ -325.72M | ¥ -412.42M | ¥ -427.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.57B | ¥ 1.41B | ¥ 1.35B | ¥ 1.99B | ¥ 2.06B |
| Total Assets | ¥ 2.24B | ¥ 2.14B | ¥ 2.12B | ¥ 2.71B | ¥ 2.64B |
| Total Debt | ¥ 185.96M | ¥ 257.08M | ¥ 345.39M | ¥ 637.27M | ¥ 222.81M |
| Net Debt | ¥ -926.16M | ¥ -828.91M | ¥ -723.80M | ¥ -166.04M | ¥ 37.48M |
| Total Liabilities | ¥ 409.87M | ¥ 465.00M | ¥ 559.86M | ¥ 834.80M | ¥ 366.44M |
| Stockholders' Equity | ¥ 1.83B | ¥ 1.67B | ¥ 1.56B | ¥ 1.87B | ¥ 2.27B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 0.00 | ¥ -239.02M | ¥ -429.96M | ¥ -478.72M | ¥ -438.00M |
| Operating Cash Flow | ¥ 0.00 | ¥ -202.84M | ¥ -300.31M | ¥ -320.60M | ¥ -347.18M |
| Investing Cash Flow | ¥ 0.00 | ¥ -18.11M | ¥ 850.76M | ¥ 574.26M | ¥ -1.52B |
| Financing Cash Flow | ¥ 0.00 | ¥ 218.07M | ¥ -310.90M | ¥ 363.90M | ¥ 186.58M |